Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400088855Phase 4Not yet recruiting
Phase 4, randomised trial in hypotension comparing Group A: esketamine + propofol with Group B: sufentanil + propofol (2 arms). Primary endpoint: Incidence of hypotension. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400088855.